{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:35Z","timestamp":1792834715844,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["T11502056"],"award-info":[{"award-number":["T11502056"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pdpdt.2026.105671","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:16:20Z","timestamp":1790810180000},"page":"105671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["OCT angiography and structural biomarker outcomes of faricimab versus aflibercept in treatment-na\u00efve polypoidal choroidal vasculopathy"],"prefix":"10.1016","volume":"62","author":[{"given":"Ai-Hua","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Min","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3200-5263","authenticated-orcid":false,"given":"Chun-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-4194","authenticated-orcid":false,"given":"Kuan-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-1067","authenticated-orcid":false,"given":"Yu-Kuei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105671_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OPTH.S385827","article-title":"Polypoidal choroidal vasculopathy: an update on diagnosis and treatment","volume":"Volume 17","author":"Sen","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0002","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0003","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"PLANET investigators, efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMa Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/aos.16797","article-title":"Efficacy of intravitreal faricimab therapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis","volume":"103","author":"Arnold-Vangsted","year":"2025","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0005","article-title":"Design and rationale of the SALWEEN Trial: a phase 3b\/4 study of faricimab, a dual angiopoietin-2 and vascular endothelial growth factor-A inhibitor, in Patients With Polypoidal Choroidal","author":"Lee","year":"2025","journal-title":"Vasculopathy"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0006","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/s41433-025-03980-2","article-title":"One-year outcomes of faricimab versus aflibercept treatment for polypoidal choroidal vasculopathy: a comparative study","volume":"39","author":"Cho","year":"2025","journal-title":"Eye"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/JCMA.0000000000001320","article-title":"Early anatomical outcomes of faricimab vs aflibercept 2\u2009mg in treatment-na\u00efve neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: a head-to-head comparative study in Taiwan","volume":"89","author":"Yang","year":"2026","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2025.104531","article-title":"Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy","volume":"52","author":"Kuo","year":"2025","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.62.15.5","article-title":"Choroidal changes in eyes with polypoidal Choroidal vasculopathy after anti-VEGF therapy imaged with swept-source OCT angiography","volume":"62","author":"Shen","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/2515841419831152","article-title":"Polypoidal choroidal vasculopathy: a comprehensive clinical update","volume":"11","author":"Kumar","year":"2019","journal-title":"Ophthalmol. Eye Dis."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0011","doi-asserted-by":"crossref","first-page":"22210","DOI":"10.1038\/s41598-025-07766-0","article-title":"Survival benefit of postoperative chemotherapy in stage III lung squamous cell carcinoma based on SEER database analysis through propensity score matching","volume":"15","author":"Xu","year":"2025","journal-title":"Scie. Repo."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0012","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ophtha.2024.11.023","article-title":"Anatomic outcomes with Faricimab vs Aflibercept in head-to-head dosing phase of the TENAYA\/LUCERNE trials in neovascular age-related macular degeneration","volume":"132","author":"Cheung","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0013","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000548709","article-title":"Polypoidal choroidal Vasculopathy: from clinicopathological and molecular perspectives","volume":"68","author":"Zhang","year":"2025","journal-title":"Ophthalmic. Res."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0014","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (L.)"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0015","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910666","article-title":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases","volume":"11","author":"Regula","year":"2019","journal-title":"EMBo Mol. Med."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0016","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ophtha.2008.12.039","article-title":"Diabetic Retinopathy Research Group Vienna, optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema","volume":"116","author":"Bolz","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0017","doi-asserted-by":"crossref","first-page":"eaau6732","DOI":"10.1126\/sciadv.aau6732","article-title":"Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration","volume":"5","author":"Kim","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0018","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s40123-024-00967-2","article-title":"Analysis of Choriocapillaris reperfusion topography following Faricimab treatment for neovascular age-related macular degeneration in therapy-na\u00efve patients","volume":"13","author":"Brinkmann","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.pdpdt.2026.105671_bib0019","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/IAE.0000000000000765","article-title":"Image artifacts in optical coherence angiography","volume":"35","author":"Spaide","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2026.105671_bib0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.21037\/qims-20-730","article-title":"Artifacts and artifact removal in optical coherence tomographic angiography","volume":"11","author":"Hormel","year":"2020","journal-title":"Quant. ImAging Med. Surg."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026003388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026003388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:58:42Z","timestamp":1792832322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026003388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"alternative-id":["S1572100026003388"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105671","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OCT angiography and structural biomarker outcomes of faricimab versus aflibercept in treatment-na\u00efve polypoidal choroidal vasculopathy","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105671"}}